| scholarly article | Q13442814 |
| P50 | author | Dafna D. Gladman | Q37605821 |
| P2093 | author name string | Urowitz MB | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| P304 | page(s) | 223-226 | |
| P577 | publication date | 1987-06-01 | |
| P1433 | published in | The Journal of rheumatology. Supplement | Q27711737 |
| P1476 | title | Morbidity in systemic lupus erythematosus | |
| P478 | volume | 14 Suppl 13 |
| Q35953274 | African-American and Hispanic ethnicities, renal involvement and obesity predispose to hypertension in systemic lupus erythematosus: results from LUMINA, a multiethnic cohort (LUMINAXLV) |
| Q34108806 | Atherosclerosis and systemic lupus erythematosus |
| Q34338929 | Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus |
| Q27008927 | Cardiorheumatology: cardiac involvement in systemic rheumatic disease |
| Q37425906 | Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors |
| Q34108825 | Circulating endothelial cells and vascular injury in systemic lupus erythematosus |
| Q36679823 | Corticosteroids: do they damage the cardiovascular system? |
| Q34137840 | Dysfunctional, pro-inflammatory HDL directly upregulates monocyte PDGFRβ, chemotaxis and TNFα production |
| Q37582574 | Epidemiology of atherosclerosis in systemic lupus erythematosus |
| Q33379277 | Factors associated with metabolic syndrome in patients with systemic lupus erythematosus from Puerto Rico. |
| Q73704286 | High prevalence of asymptomatically poor muscle perfusion of lower extremities measured in systemic lupus erythematosus patients with abnormal myocardial perfusion |
| Q35840758 | Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study |
| Q36840240 | Kidney disease in systemic lupus erythematosus |
| Q33730536 | Management of cardiovascular complications in systemic lupus erythematosus |
| Q35636684 | Modification of hypertension and hypercholesterolaemia in patients with systemic lupus erythematosus: a quality improvement study |
| Q36697443 | Mycophenolate mofetil (MMF) does not slow the progression of subclinical atherosclerosis in SLE over 2 years |
| Q35552164 | Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus |
| Q89947833 | No association of complement mannose-binding lectin deficiency with cardiovascular disease in patients with Systemic Lupus Erythematosus |
| Q38230699 | Pathogenesis and treatment of atherosclerosis in lupus |
| Q33564222 | Peripheral vascular disease in patients with systemic lupus erythematosus |
| Q41915915 | Polymorphism of the β3-adrenergic receptor and lipid profile in patients with rheumatoid arthritis and systemic lupus erythematosus treated with chloroquine |
| Q35639129 | Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus |
| Q37635186 | Prevalence and associated factors of resting electrocardiogram abnormalities among systemic lupus erythematosus patients without cardiovascular disease. |
| Q51464078 | Prevalence and factors associated with dyslipoproteinemias in Brazilian systemic lupus erythematosus patients. |
| Q40506590 | Prognosis in systemic lupus erythematosus |
| Q59797299 | Progression of subclinical and clinical cardiovascular disease in a UK SLE cohort: the role of classic and SLE-related factors |
| Q37188698 | Relation of carotid intima-media thickness and plaque with incident cardiovascular events in women with systemic lupus erythematosus |
| Q36056947 | Risk factors for coronary heart disease in connective tissue diseases |
| Q35552185 | Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus |
| Q36644837 | Risk factors in cardiovascular disease in systemic lupus erythematosus |
| Q36906572 | Short-term perioperative all-cause mortality and cardiovascular events in women with systemic lupus erythematosus |
| Q47889345 | Survival of patients with SLE admitted to an intensive care unit-a retrospective study |
| Q37033345 | Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention |
| Q53211404 | The SLICC inception cohort for atherosclerosis. |
| Q33818710 | Use of atorvastatin in systemic lupus erythematosus in children and adolescents |
| Q73813324 | Usefulness of thallium-201 muscle scan to investigate perfusion reserve in the lower limbs of patients with systemic lupus erythematusus |
| Q34027673 | Variability over time and correlates of cholesterol and blood pressure in systemic lupus erythematosus: a longitudinal cohort study |
| Q43659943 | Variables associated with decreased survival in systemic lupus erythematosus |
| Q81772558 | [Accelerated atherosclerosis in rheumatic systemic diseases as an example of systemic lupus erythematosus--what is the consequence?] |
Search more.